Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 176

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

Boehm, B. O., Home, P. D., Behrend, C., Kamp, N. M., Lindholm, A. · 2002 · Diabetic Medicine

Abstract

Aim To compare the efficacy and safety of premixed insulin aspart (30% free and 70% protamine‐bound, BIAsp 30) with human insulin premix (BHI 30) used in a twice‐daily injection regimen in people with Type 1 and Type 2 diabetes. Methods People with Type 1 and Type 2 diabetes (n = 294) using twice‐daily insulin were randomized to a 12‐week open‐label comparison of BIAsp 30 and BHI 30. Efficacy was assessed by analysis of variance of 12‐week data, adjusted for baseline level. Results BIAsp 30 was as effective as BHI 30 based on the primary efficacy measure, HbA 1c, mean difference –0.01 (90% confidence interval (CI) –0.14; 0.12) %Hb. Meal‐time self‐measured blood glucose increment averaged over the three main meals was significantly lower in the BIAsp 30 group than in the BHI 30 group (–0.68 (–1.20; –0.16) mmol/l; P < 0.02). Significant improvements were observed after breakfast, before lunch, after dinner and at bedtime (P < 0.02–0.05), with blood glucose around 1.0 mmol/l lower in the BIAsp 30 group. The number of major hypoglycaemic episodes with BIAsp 30 was half that with BHI 30. However, the overall risk of both minor and major hypoglycaemia did not differ significantly between treatments. Conclusion Post‐prandial glycaemic control was significantly improved, without increasing the risk of hypoglycaemia, and overall control was similar when people with Type 1 and Type 2 diabetes were treated on a twice‐daily regimen with immediate premeal injections of BIAsp 30 compared with BHI 30. Diabet. Med. 19, 393–399 (2002)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.2002.00733.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 176

Metadata

Authors
Boehm, B. O., Home, P. D., Behrend, C., Kamp, N. M., & Lindholm, A.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2002-05
Volume
19
Issue
5
Pages
393-399
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1512877138
Cited by
176
References
2
FWCI
6.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients. https://app.cochat.ai/papers/10.1046/j.1464-5491.2002.00733.x
The paper
Boehm, B. O., Home, P. D., Behrend, C., Kamp, N. M., & Lindholm, A. (2002). Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2002.00733.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.